FedCircuitBlog

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today we highlight:

• an article suggesting the Federal Circuit in a recent opinion “explored and clarified” the limits on how a court can correct errors in patents;
• a blog post indicating another recent Federal Circuit decision answers the question of “[w]hat value” a patent has when it “expires before it issues”;
• an article explaining how the Supreme Court’s “unanimous decision in Hikma v. Amarin fundamentally altered the legal landscape for generic pharmaceutical manufacturers, imposing a stricter standard for what constitutes patent infringement liability and potentially clearing a path for lower-cost alternatives to reach patients sooner”; and
• an article arguing President Trump’s “new Section 301 tariffs . . . run afoul of the major questions doctrine, which requires Congress to ‘speak clearly’ when authorizing the executive to make decisions of ‘vast economic and political significance.’”

Here is a report on recent news and commentary related to the Federal Circuit and its cases. Today’s report highlights:

• a blog post discussing how a recent decision in a patent case by the Federal circuit focuses “on a novel argument about provisional rights”;
• another blog post discussing how a recent Federal Circuit decision “illustrates circumstances under which the [Patent Trial and Appeal] Board’s obviousness determination did not pass muster.”;
• a piece reporting how the Council for Innovation Promotion recently released a report “urging the Trump Administration and Congress to take 18 key steps to strengthen the U.S. IP system”; and
• a report claiming a recent Federal Circuit decision “has created pitfalls for entities using a type of patent claim that describes an improvement on previous technology, making the so-called Jepson format, which is already uncommon, even less appealing for applicants.”

This morning, the Federal Circuit released one precedential opinion, two nonprecedential opinions, and one nonprecedential order. The precedential opinion comes in a patent case on appeal from the Patent Trial and Appeal Board. Both of the nonprecedential opinions come in appeals from the Court of Federal Claims, one in a government contract case and one in a vaccine case. The nonprecedential order dismisses an appeal. Here are the introductions to the opinions and order.